How to Get Cometriq (Cabozantinib) Covered by Aetna CVS Health in Illinois: Prior Authorization Guide and Appeals Process
Answer Box: Getting Cometriq Covered by Aetna CVS Health in Illinois
Cometriq (cabozantinib) requires prior authorization from Aetna CVS Health for medullary thyroid carcinoma (MTC) coverage. Submit your PA request via the Availity provider portal or fax to 1-888-267-3277 with oncologist attestation, confirmed MTC diagnosis, and documentation of disease progression. Standard review takes 1-5 business days. If denied, Illinois patients have 180 days to appeal internally and 30 days after final denial for external review through the Illinois Department of Insurance.
First step today: Contact your oncologist to initiate the prior authorization request with complete clinical documentation including pathology confirmation and staging.
Table of Contents
- Coverage Requirements at a Glance
- Step-by-Step: Fastest Path to Approval
- Required Documentation
- Common Denial Reasons & Solutions
- Appeals Process in Illinois
- Cost Assistance Programs
- FAQ
Coverage Requirements at a Glance
| Requirement | Details | Source |
|---|---|---|
| Prior Authorization | Required for all Cometriq prescriptions | Aetna Specialty Drug List |
| Formulary Tier | Tier 4 specialty medication | Aetna Formulary |
| Prescriber Requirement | Oncologist or specialist consultation required | CVS Caremark Policy |
| Diagnosis Code | C73 (Malignant neoplasm of thyroid gland) | ICD-10 Reference |
| Quantity Limits | 112 capsules per 28 days (140mg daily dose) | Aetna Quantity Limits |
| Step Therapy | Documentation of prior treatment attempts | PA Form Requirements |
Step-by-Step: Fastest Path to Approval
1. Verify Coverage and Benefits
Who: Patient or clinic staff
Action: Call Aetna member services at the number on your insurance card
Timeline: 5-10 minutes
What to ask: "Is Cometriq covered under my plan? What's my specialty medication copay?"
2. Gather Required Documentation
Who: Healthcare team
Documents needed:
- Pathology report confirming MTC diagnosis
- Current staging and imaging studies
- Complete treatment history with dates and outcomes
- Current labs (liver and kidney function)
- Prescriber DEA and NPI numbers
3. Submit Prior Authorization Request
Who: Prescribing physician or authorized staff
Method: Availity portal (fastest) or fax 1-888-267-3277
Form: Aetna PA Request Form
Timeline: Submit during business hours for same-day processing
4. Follow Up on Status
When: 2-3 business days after submission
Method: Provider portal or call 1-855-240-0535
What to track: Reference number, review status, additional information requests
5. Coordinate Specialty Pharmacy
Who: Patient and clinic
Action: Once approved, Aetna will direct you to CVS Specialty or network pharmacy
Timeline: 2-3 days for first fill after approval
Tip: Mark urgent requests as "expedited" if treatment delay would seriously jeopardize health. Illinois law requires expedited reviews within 24-72 hours.
Required Documentation
Clinical Documentation Checklist
Diagnosis Confirmation:
- ✓ Pathology report with confirmed medullary thyroid carcinoma
- ✓ Current staging (stage III or IV for metastatic disease)
- ✓ Recent imaging showing disease progression per RECIST criteria
Treatment History:
- ✓ Prior therapies attempted with specific dates
- ✓ Documented treatment failures or intolerances
- ✓ Contraindications to alternative treatments (e.g., vandetanib)
- ✓ Current performance status assessment
Laboratory Requirements:
- ✓ Complete blood count
- ✓ Comprehensive metabolic panel
- ✓ Liver function tests (AST, ALT, bilirubin)
- ✓ Blood pressure readings (must be controlled)
Prescriber Attestation
Your oncologist must attest to:
- Medical necessity for Cometriq specifically
- Why formulary alternatives are inappropriate
- Patient's ability to tolerate oral therapy
- Monitoring plan for side effects
Common Denial Reasons & Solutions
| Denial Reason | Solution | Documentation Needed |
|---|---|---|
| Step therapy not met | Document prior treatment failures | Complete therapy history with dates, doses, and outcomes |
| Non-formulary status | Request formulary exception | Clinical superiority evidence and contraindications to alternatives |
| Quantity limit exceeded | Justify dosing requirements | Weight-based calculations and toxicity management plan |
| Diagnosis not supported | Provide pathology confirmation | Original pathology report and staging documentation |
| Formulation confusion | Specify Cometriq capsules | Explicit note that Cometriq capsules (not Cabometyx tablets) required for MTC |
Note: A common error is requesting Cabometyx tablets instead of Cometriq capsules. These formulations are not interchangeable for MTC treatment.
Appeals Process in Illinois
Internal Appeal (First Level)
Deadline: 180 days from denial notice
Method: Written appeal to address on denial letter
Timeline: 15 business days for standard review, 24 hours for expedited
Required: Copy of denial letter, additional clinical documentation, prescriber letter
External Review (Independent Review)
Deadline: 30 days after final internal appeal denial
Authority: Illinois Department of Insurance
Phone: 1-877-527-9431
Timeline: 5 business days after IRO receives all materials
Cost: No fee to consumer
Key Illinois-Specific Rights
- Binding decision: External review decisions are binding on Aetna
- Physician reviewer: Board-certified specialist with relevant expertise
- Fast track: 24-72 hours for urgent cases
- Consumer assistance: Illinois Attorney General Health Care Helpline at 1-877-305-5145
Counterforce Health specializes in transforming insurance denials into targeted, evidence-backed appeals. Their platform analyzes denial letters and plan policies to draft point-by-point rebuttals aligned with payer requirements, pulling the right clinical evidence and citations to support your case.
Cost Assistance Programs
Manufacturer Support
- Exelixis Patient Assistance Program: Income-based free drug program
- Cometriq Copay Card: May reduce out-of-pocket costs (commercial insurance only)
- Contact: 1-855-500-EXEL (3935) or cometriq.com
Foundation Resources
- Patient Advocate Foundation: Copay relief program
- CancerCare: Financial assistance for cancer patients
- Leukemia & Lymphoma Society: Patient aid program
Illinois State Resources
- Illinois Department of Healthcare and Family Services: Medicaid coverage options
- Illinois Cancer Care: State-sponsored patient navigation services
FAQ
How long does Aetna CVS Health prior authorization take for Cometriq in Illinois? Standard review takes 1-5 business days with complete documentation. Expedited requests (marked urgent) are processed within 24-72 hours per Illinois requirements.
What if Cometriq is non-formulary on my plan? Request a formulary exception with clinical documentation showing why formulary alternatives are inappropriate. Include contraindications, prior failures, or medical reasons why Cometriq is superior.
Can I get an expedited appeal in Illinois? Yes, if treatment delay would seriously jeopardize your health. Illinois law requires expedited appeals within 24 hours for internal review and 24-72 hours for external review.
Does step therapy apply if I tried treatments outside Illinois? Yes, document all prior treatments regardless of where they occurred. Include complete records with dates, doses, duration, and reasons for discontinuation.
What's the difference between Cometriq and Cabometyx? Cometriq (capsules) is FDA-approved for medullary thyroid carcinoma. Cabometyx (tablets) is not approved for MTC and cannot be substituted. Specify Cometriq capsules in all requests.
How much does Cometriq cost without insurance? Cash prices average around $18,938 for a 28-day supply. Patient assistance programs may significantly reduce costs based on income eligibility.
Can my primary care doctor prescribe Cometriq? Aetna typically requires prescription by or consultation with an oncologist for specialty cancer medications like Cometriq.
What happens if my appeal is denied? After internal appeal denial, you have 30 days to request external review through the Illinois Department of Insurance. This independent physician review is binding on Aetna.
From our advocates: We've seen cases where initial denials for "non-formulary status" were quickly overturned when the appeal included specific documentation of vandetanib contraindications and clear pathology confirmation of MTC. The key is providing complete clinical rationale upfront rather than minimal documentation that requires back-and-forth requests.
When facing complex prior authorization requirements, platforms like Counterforce Health can help streamline the process by identifying specific denial reasons and crafting targeted responses that align with Aetna's coverage policies.
Sources & Further Reading
- Aetna Specialty Drug List 2025
- Aetna Prior Authorization Forms
- Illinois Department of Insurance External Review
- Cometriq Prescribing Information
- CVS Caremark Specialty Pharmacy
- Illinois Attorney General Health Care Helpline
Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Coverage policies and requirements may change. Always verify current information with your insurance plan and healthcare providers. For personalized assistance with insurance appeals and coverage issues, consult with qualified professionals or contact the Illinois Department of Insurance consumer assistance programs.
Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.